About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Diagnostic Accuracy and Utility of ZTE Added to Routine MRI

NCT07882147·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Amal Ahmed Helmy

Age

18–75

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Female patients
Referred for diagnostic or staging breast MRI
Mammogram available within the previous 6 months, or a biopsy marker in place.
Able to provide informed consent and tolerate MRI positioning.

You may not be if

\- MRI contraindications (e.g., pacemaker or other MRI-unsafe implant, severe claustrophobia).
Pregnancy or lactation.
Contraindication to gadolinium.
Prior mastectomy or breast radiation.
Severe motion artifact

The record

StatusNot yet recruiting

PhaseNo phase

Taking part100

StartedDec 2026

UpdatedOct 20, 2026

Conditions

Breast Cancer MRI Imaging

Clareo Health | Diagnostic Accuracy and Utility of ZTE Added to Routine MRI